in vitro-treated peripheral blood stem cell transplantation [clinicaltrials_resource:9ea3c78d54070f1ed0b8d9e42c1529d2]
Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003399]Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00003727]Vaccine Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00003792]Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Small Cell Lung Cancer [clinicaltrials:NCT00003860]Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia [clinicaltrials:NCT00003874]Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer [clinicaltrials:NCT00003877]Gene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma [clinicaltrials:NCT00003942]Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer [clinicaltrials:NCT00003977]Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia [clinicaltrials:NCT00004878]Stem Cell Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00004904]Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma [clinicaltrials:NCT00005787]Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00005986]Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease [clinicaltrials:NCT00005998]Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer [clinicaltrials:NCT00006225]Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Low- or Intermediate-Grade Non-Hodgkin's Lymphoma [clinicaltrials:NCT00006241]Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian Cancer [clinicaltrials:NCT00019916]Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma [clinicaltrials:NCT00027937]Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder [clinicaltrials:NCT00049634]Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00091104]Autologous Peripheral Stem Cell or Bone Marrow Transplant Using Laboratory-Treated Cells in Treating Patients With Acute Leukemia [clinicaltrials:NCT00245115]Laboratory-Treated Peripheral Blood Cell Infusion After Donor Stem Cell Transplant in Treating Patients With Hematologic Cancers or Other Diseases [clinicaltrials:NCT00376480]clinicaltrials:NCT00450983
intervention [clinicaltrials_vocabulary:intervention]
in vitro-treated peripheral blood stem cell transplantation [clinicaltrials_resource:9ea3c78d54070f1ed0b8d9e42c1529d2]
Bio2RDF identifier
9ea3c78d54070f1ed0b8d9e42c1529d2
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:9ea3c78d54070f1ed0b8d9e42c1529d2
intervention name [clinicaltrials_vocabulary:intervention-name]
in vitro-treated peripheral blood stem cell transplantation
identifier
clinicaltrials_resource:9ea3c78d54070f1ed0b8d9e42c1529d2
title
in vitro-treated peripheral blood stem cell transplantation
@en
type
label
in vitro-treated peripheral bl ...... 3c78d54070f1ed0b8d9e42c1529d2]
@en